Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Prevention of recurrent urinary stone disease.

Goka SQ, Copelovitch L.

Curr Opin Pediatr. 2019 Nov 26. doi: 10.1097/MOP.0000000000000852. [Epub ahead of print]

PMID:
31790032
2.

Predictors of time to first cannulation for arteriovenous fistula in pediatric hemodialysis patients: Midwest Pediatric Nephrology Consortium study.

Onder AM, Flynn JT, Billings AA, Deng F, DeFreitas M, Katsoufis C, Grinsell MM, Patterson L, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L, Ellis E, Chadha V, Elmaghrabi A, Lin JJ, Butani L, Haddad M, Marsenic O, Brakeman P, Quigley R, Shin HS, Garro R, Liu H, Rahimikollu J, Raina R, Langman CB, Wood E; Midwest Pediatric Nephrology Consortium.

Pediatr Nephrol. 2020 Feb;35(2):287-295. doi: 10.1007/s00467-019-04396-3. Epub 2019 Nov 6.

PMID:
31696356
3.

Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.

Vajravelu RK, Copelovitch L, Osterman MT, Scott FI, Mamtani R, Lewis JD, Denburg MR.

Clin Gastroenterol Hepatol. 2019 Nov 1. pii: S1542-3565(19)31245-5. doi: 10.1016/j.cgh.2019.10.043. [Epub ahead of print]

PMID:
31683056
4.

New insights into the pathogenesis of Streptococcus pneumoniae-associated hemolytic uremic syndrome.

Scobell RR, Kaplan BS, Copelovitch L.

Pediatr Nephrol. 2019 Sep 13. doi: 10.1007/s00467-019-04342-3. [Epub ahead of print] Review.

PMID:
31515631
5.

Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.

Onder AM, Flynn JT, Billings AA, Deng F, DeFreitas M, Katsoufis C, Grinsell MM, Patterson LT, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L, Ellis E, Chadha V, Elmaghrabi A, Lin JJ, Butani L, Haddad M, Couloures OM, Brakeman P, Quigley R, Shin HS, Garro R, Liu H, Rahimikollu J, Raina R, Langman CB, Wood EG; Midwest Pediatric Nephrology Consortium.

Pediatr Nephrol. 2019 Aug;34(8):1483-1484. doi: 10.1007/s00467-019-4199-0.

PMID:
30684015
6.

Update on Dent Disease.

Ehlayel AM, Copelovitch L.

Pediatr Clin North Am. 2019 Feb;66(1):169-178. doi: 10.1016/j.pcl.2018.09.003. Review.

PMID:
30454742
7.

Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.

Onder AM, Flynn JT, Billings AA, Deng F, DeFreitas M, Katsoufis C, Grinsell MM, Patterson LT, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L, Ellis E, Chanda V, Elmaghrabi A, Lin JJ, Butani L, Haddad M, Couloures OM, Brakeman P, Quigley R, Stella Shin H, Garro R, Liu H, Rahimikollu J, Raina R, Langman CB, Wood EG; Midwest Pediatric Nephrology Consortium.

Pediatr Nephrol. 2019 Feb;34(2):329-339. doi: 10.1007/s00467-018-4082-4. Epub 2018 Sep 27. Erratum in: Pediatr Nephrol. 2019 Jan 25;:.

PMID:
30264215
8.

Oral Antibiotic Exposure and Kidney Stone Disease.

Tasian GE, Jemielita T, Goldfarb DS, Copelovitch L, Gerber JS, Wu Q, Denburg MR.

J Am Soc Nephrol. 2018 Jun;29(6):1731-1740. doi: 10.1681/ASN.2017111213. Epub 2018 May 10.

9.

Pretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.

Le Palma K, Pavlick ER, Copelovitch L.

Clin Kidney J. 2018 Apr;11(2):166-171. doi: 10.1093/ckj/sfx138. Epub 2017 Dec 21.

10.

Uncommon cribfellows: an infant with hypercalcemia, nephrocalcinosis, and acidosis: Answers.

Ehlayel AM, Copelovitch L.

Pediatr Nephrol. 2018 Oct;33(10):1697-1699. doi: 10.1007/s00467-018-3912-8. Epub 2018 Feb 19. No abstract available.

PMID:
29460158
11.

Uncommon cribfellows: an infant with hypercalcemia, nephrocalcinosis, and acidosis: Questions.

Ehlayel AM, Copelovitch L.

Pediatr Nephrol. 2018 Oct;33(10):1695. doi: 10.1007/s00467-018-3887-5. Epub 2018 Feb 19. No abstract available.

PMID:
29460157
12.

Variability in measures of mineral metabolism in children on hemodialysis: impact on clinical decision-making.

Kakajiwala A, Jemielita TO, Copelovitch L, Leonard MB, Furth SL, York A, Benton M, Hoofnagle AN, Windt K, Merrigan K, Lederman A, Denburg MR.

Pediatr Nephrol. 2017 Dec;32(12):2311-2318. doi: 10.1007/s00467-017-3730-4. Epub 2017 Jun 30.

PMID:
28667458
13.

Risk of Urolithiasis in Anorexia Nervosa: A Population-Based Cohort Study Using the Health Improvement Network.

Denburg MR, Leonard MB, Jemielita TO, Golden NH, Tasian G, Copelovitch L.

Eur Eat Disord Rev. 2017 Sep;25(5):406-410. doi: 10.1002/erv.2526. Epub 2017 Jun 29.

PMID:
28660717
14.

Salt, sweat, and unclear? Diaphoresis and hypernatremia in end-stage kidney disease: Answers.

Levy Erez D, Copelovitch L, Denburg M.

Pediatr Nephrol. 2018 Feb;33(2):253-254. doi: 10.1007/s00467-017-3668-6. Epub 2017 Apr 27. No abstract available.

15.

Salt, sweat, and unclear? Diaphoresis and hypernatremia in end-stage kidney disease: Questions.

Levy Erez D, Copelovitch L, Denburg M.

Pediatr Nephrol. 2018 Feb;33(2):251-252. doi: 10.1007/s00467-017-3667-7. Epub 2017 Apr 27.

16.

Assessment of Sex Differences in Fracture Risk Among Patients With Anorexia Nervosa: A Population-Based Cohort Study Using The Health Improvement Network.

Nagata JM, Golden NH, Leonard MB, Copelovitch L, Denburg MR.

J Bone Miner Res. 2017 May;32(5):1082-1089. doi: 10.1002/jbmr.3068. Epub 2017 Jan 19.

17.

Dietary Zinc and Incident Calcium Kidney Stones in Adolescence.

Tasian GE, Ross ME, Song L, Grundmeier RW, Massey J, Denburg MR, Copelovitch L, Warner S, Chi T, Killilea DW, Stoller ML, Furth SL.

J Urol. 2017 May;197(5):1342-1348. doi: 10.1016/j.juro.2016.11.096. Epub 2016 Nov 23.

18.

Pediatric Kidney Stones - Avoidance and Treatment.

Chu DI, Tasian GE, Copelovitch L.

Curr Treat Options Pediatr. 2016 Jun;2(2):104-111. Epub 2016 Mar 21.

19.

Glomerular Pathology in Dent Disease and Its Association with Kidney Function.

Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, Harris PC, Lieske JC; Investigators of the Rare Kidney Stone Consortium.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2168-2176. Epub 2016 Oct 3.

20.

Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?

Kakajiwala A, Bhatti T, Kaplan BS, Ruebner RL, Copelovitch L.

Clin Kidney J. 2016 Feb;9(1):90-6. doi: 10.1093/ckj/sfv119. Epub 2015 Nov 26.

21.

Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012.

Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, Chu DI, Copelovitch L, Saigal CS, Furth SL.

Clin J Am Soc Nephrol. 2016 Mar 7;11(3):488-96. doi: 10.2215/CJN.07610715. Epub 2016 Jan 14.

22.

Assessing the risk of incident hypertension and chronic kidney disease after exposure to shock wave lithotripsy and ureteroscopy.

Denburg MR, Jemielita TO, Tasian GE, Haynes K, Mucksavage P, Shults J, Copelovitch L.

Kidney Int. 2016 Jan;89(1):185-92. doi: 10.1038/ki.2015.321. Epub 2016 Jan 4.

23.

Making every drop count for pediatric kidney transplant patients.

Clark SL, Taylor A, Shaw KN, Copelovitch L.

Hosp Pediatr. 2015 May;5(5):287-9. doi: 10.1542/hpeds.2014-0146. No abstract available.

24.

Current treatment of atypical hemolytic uremic syndrome.

Kaplan BS, Ruebner RL, Spinale JM, Copelovitch L.

Intractable Rare Dis Res. 2014 May;3(2):34-45. doi: 10.5582/irdr.2014.01001. Review.

25.

Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network.

Denburg MR, Leonard MB, Haynes K, Tuchman S, Tasian G, Shults J, Copelovitch L.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2133-40. doi: 10.2215/CJN.04340514. Epub 2014 Oct 23.

26.

Evaluation and medical management of kidney stones in children.

Tasian GE, Copelovitch L.

J Urol. 2014 Nov;192(5):1329-36. doi: 10.1016/j.juro.2014.04.108. Epub 2014 Jun 21. Review.

PMID:
24960469
27.

Genetics and urinary tract malformations.

Copelovitch L, Furth SL.

Am J Kidney Dis. 2014 Feb;63(2):183-5. doi: 10.1053/j.ajkd.2013.11.005. Epub 2013 Dec 4. No abstract available.

PMID:
24315771
28.

Nephrotic syndrome associated with tyrosine kinase inhibitors for pediatric malignancy: case series and review of the literature.

Ruebner RL, Copelovitch L, Evageliou NF, Denburg MR, Belasco JB, Kaplan BS.

Pediatr Nephrol. 2014 May;29(5):863-9. doi: 10.1007/s00467-013-2696-0. Epub 2013 Dec 7.

PMID:
24310825
29.

Renal-hepatic-pancreatic dysplasia: a sibship with skeletal and central nervous system anomalies and NPHP3 mutation.

Copelovitch L, O'Brien MM, Guttenberg M, Otto EA, Kaplan BS.

Am J Med Genet A. 2013 Jul;161A(7):1743-9. doi: 10.1002/ajmg.a.35958. Epub 2013 May 17.

PMID:
23686967
30.

Update on Streptococcus pneumoniae associated hemolytic uremic syndrome.

Spinale JM, Ruebner RL, Kaplan BS, Copelovitch L.

Curr Opin Pediatr. 2013 Apr;25(2):203-8. doi: 10.1097/MOP.0b013e32835d7f2c. Review.

PMID:
23481474
31.

Long-term outcomes of Shiga toxin hemolytic uremic syndrome.

Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS.

Pediatr Nephrol. 2013 Nov;28(11):2097-105. doi: 10.1007/s00467-012-2383-6. Epub 2013 Jan 4. Review.

PMID:
23288350
32.

Urolithiasis in children: medical approach.

Copelovitch L.

Pediatr Clin North Am. 2012 Aug;59(4):881-96. doi: 10.1016/j.pcl.2012.05.009. Epub 2012 Jun 15. Review.

33.

A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?

Ruebner RL, Kaplan BS, Copelovitch L.

Eur J Pediatr. 2012 Oct;171(10):1519-25. Epub 2012 Jun 7.

PMID:
22673930
34.

Multiple residues in the distal C terminus of the α-subunit have roles in modulating human epithelial sodium channel activity.

Mueller GM, Yan W, Copelovitch L, Jarman S, Wang Z, Kinlough CL, Tolino MA, Hughey RP, Kleyman TR, Rubenstein RC.

Am J Physiol Renal Physiol. 2012 Jul 15;303(2):F220-8. doi: 10.1152/ajprenal.00493.2011. Epub 2012 May 9.

35.

Insights from the Chronic Kidney Disease in Children (CKiD) study.

Copelovitch L, Warady BA, Furth SL.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2047-53. doi: 10.2215/CJN.10751210. Epub 2011 Jul 22. Review.

36.

Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America.

Banerjee R, Hersh AL, Newland J, Beekmann SE, Polgreen PM, Bender J, Shaw J, Copelovitch L, Kaplan BS, Shah SS; Emerging Infections Network Hemolytic-Uremic Syndrome Study Group.

Pediatr Infect Dis J. 2011 Sep;30(9):736-9. doi: 10.1097/INF.0b013e3182191c58.

PMID:
21772230
37.

An expanded syndrome of dRTA with hearing loss, hyperoxaluria and beta2-microglobulinuria.

Copelovitch L, Kaplan BS.

NDT Plus. 2010 Oct;3(5):439-42. doi: 10.1093/ndtplus/sfq123. Epub 2010 Jul 12.

38.

Evidence for a recurrent microdeletion at chromosome 16p11.2 associated with congenital anomalies of the kidney and urinary tract (CAKUT) and Hirschsprung disease.

Sampson MG, Coughlin CR 2nd, Kaplan P, Conlin LK, Meyers KE, Zackai EH, Spinner NB, Copelovitch L.

Am J Med Genet A. 2010 Oct;152A(10):2618-22. doi: 10.1002/ajmg.a.33628.

PMID:
20799338
39.

Streptococcus pneumoniae--associated hemolytic uremic syndrome: classification and the emergence of serotype 19A.

Copelovitch L, Kaplan BS.

Pediatrics. 2010 Jan;125(1):e174-82. doi: 10.1542/peds.2007-2017. Epub 2009 Dec 21.

PMID:
20026500
40.

Childhood nephrotic syndrome in Cambodia: an association with gastrointestinal parasites.

Copelovitch L, Sam Ol O, Taraquinio S, Chanpheaktra N.

J Pediatr. 2010 Jan;156(1):76-81. doi: 10.1016/j.jpeds.2009.06.049.

PMID:
19683254
41.

The thrombotic microangiopathies.

Copelovitch L, Kaplan BS.

Pediatr Nephrol. 2008 Oct;23(10):1761-7. Epub 2007 Sep 30. Review.

42.

Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis.

Copelovitch L, Nash MA, Kaplan BS.

Clin J Am Soc Nephrol. 2007 Sep;2(5):914-8. Epub 2007 Aug 8.

43.

Streptococcus pneumoniae-associated hemolytic uremic syndrome.

Copelovitch L, Kaplan BS.

Pediatr Nephrol. 2008 Nov;23(11):1951-6. Epub 2007 Jun 13. Review.

44.

Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS.

Copelovitch L, Guttenberg M, Pollak MR, Kaplan BS.

Pediatr Nephrol. 2007 Oct;22(10):1779-84. Epub 2007 May 25.

PMID:
17530296
45.

Is genetic testing of healthy pre-symptomatic children with possible Alport syndrome ethical?

Copelovitch L, Kaplan BS.

Pediatr Nephrol. 2006 Apr;21(4):455-6. Epub 2006 Feb 21. No abstract available.

PMID:
16491420
46.

Simplified treatment strategies to fluid therapy in diarrhea.

Assadi F, Copelovitch L.

Pediatr Nephrol. 2003 Nov;18(11):1152-6. Epub 2003 Oct 2. Review. Erratum in: Pediatr Nephrol. 2004 Mar;19(3):364.

PMID:
14523638

Supplemental Content

Loading ...
Support Center